No Inconsistent Rights. The Company will not grant to a third-party any rights or enter into any arrangements or agreements that would limit or restrict the Foundation’s rights to the Global Access Commitments.
No Inconsistent Rights. The Company covenants and agrees that it shall not grant, and has not previously granted, registration rights with respect to Registrable Securities or any other securities which are inconsistent with the registration rights contained in this Agreement.
No Inconsistent Rights. Each Party represents and warrants to the other Parties that ***** as of the Effective Date it has not granted, and will not during the Term grant, any rights (implied or otherwise) inconsistent with this Agreement or any Ancillary Agreement to use such Party’s Anti-IgE Patents, Know-How or Biological Materials to any other person or entity except as expressly set forth in this Agreement and to the extent expressly contemplated and permitted herein.
No Inconsistent Rights. The Company will not hereafter enter into any agreement with respect to its securities which is inconsistent with the rights granted to the holders of Registrable Securities in this Agreement. The Company is not a party to any agreement, with respect to any of its securities, granting any registration rights to any person, which agreement is or may be inconsistent with the rights granted to the holders of Registrable Securities in this Agreement and is in effect on the date hereof or the Effective Date.
No Inconsistent Rights. There are no outstanding assignments, grants, licenses, obligations or agreements, either written, oral or implied, materially inconsistent with this Purchase Agreement and the Seller and APPI have the right to assign the Purchased Assets.
No Inconsistent Rights. Subject to the Existing Agreements, neither the Company nor Exscientia will grant to a third-party any rights or enter into any arrangements or agreements that would limit or restrict the Foundation’s ability to exercise its rights or the Company’s or Exscientia’s ability to perform its obligations under this Agreement (including the licenses granted in this Agreement). The Foundation will not be required to take any action or enter into any arrangement or agreement that would limit or restrict the Foundation’s ability to exercise its rights under this Agreement.
No Inconsistent Rights. Infinity will not hereafter enter into any agreement with respect to its securities which is inconsistent in any material respect with the rights granted to the holders of Registrable Securities in this Agreement. Except for any rights inconsistent with those granted by Infinity pursuant to the Intercompany Agreement, dated as of December 15, 1998, by and between Infinity and CBS Corporation, Infinity is not a party to any agreement, with respect to any of its securities, granting any registration rights to any person, which agreement is or may be inconsistent with the rights granted to the holders of Registrable Securities in this Agreement and is in effect on the date hereof.
No Inconsistent Rights. The Company will not enter into any agreement with respect to any of its securities that is inconsistent with the rights granted to the Holders under this Exhibit C or otherwise conflicts with the provisions hereof. EXHIBIT D FORM OF LEGAL OPINION
1. The Company is a corporation duly incorporated, validly existing and in good standing under, and by virtue of, the laws of the jurisdiction of its incorporation. The Company has requisite corporate power to own, lease and operate its properties and assets, and to carry on its business as described in the 1996 10-K, and is duly qualified to do business as a foreign corporation and is in good standing in each jurisdiction in which the failure to be so qualified would have a Material Adverse Effect (as defined below) on the Company. When used in connection with the Company, the term "Material Adverse Effect" means, for the purposes of this opinion, any event or effect that is materially adverse to the business, assets, financial condition, or results of operations of the Company and its subsidiaries taken as a whole.
No Inconsistent Rights. The Company will not grant to a third-party any rights or enter into any arrangements or agreements that would limit or restrict the Foundation’s or a Foundation-supported Entity’s ability to exercise its rights or the Company’s ability to perform its obligations under this Letter Agreement (including the Global Health License and the Foundation’s right to require Additional Projects from the list of diseases set forth in Part A of Appendix C). The Foundation will not be required to take any action or enter into any arrangement or agreement that would limit or restrict the Foundation’s ability to exercise its rights under this Letter Agreement.
No Inconsistent Rights. Shire and its Affiliates have not, as of the Effective Date, and during the Term they will not, grant or transfer any rights in the Patents that are inconsistent with (or otherwise adversely affect) the rights granted to Synageva in this Agreement.